FORECASTING THE PREVALENCE AND ECONOMIC BURDEN OF ATRIAL FIBRILLATION IN SELECTED COUNTRIES, 2010-2025

被引:0
|
作者
Rizzo, J. A. [1 ]
Mallow, P. [2 ]
Cirrincione, A. [3 ]
机构
[1] SUNY Stony Brook, Port Jeffeso, NY USA
[2] S2 Stat Solut, Cincinnati, OH USA
[3] Biosense Webster Inc, Diamond Bar, CA, Belgium
关键词
D O I
10.1016/j.jval.2012.08.886
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A351 / A351
页数:1
相关论文
共 50 条
  • [31] Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of Japan
    Hori, Masatsugu
    Ikeda, Shunya
    Okumura, Ken
    Matsuda, Shinya
    Koretsune, Yukihiro
    Montouchet, Calypso
    Watanabe-Fujinuma, Emi
    Evers, Thomas
    Rossi, Bruno
    Ruff, Lewis
    Briere, Jean-Baptiste
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (09) : 889 - 899
  • [32] The Economic Burden to Medicare of Stroke Events in Atrial Fibrillation Populations With and Without Thromboprophylaxis
    Patel, Aarti A.
    Ogden, Kristine
    Veerman, Mark
    Mody, Samir H.
    Nelson, Winnie W.
    Neil, Nancy
    POPULATION HEALTH MANAGEMENT, 2014, 17 (03) : 159 - 165
  • [33] Economic burden and co-morbidities of atrial fibrillation in a privately insured population
    Wu, EQ
    Birnbaum, EG
    Mareva, M
    Tuttle, E
    Castor, AR
    Jackman, W
    Ruskin, J
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1693 - 1699
  • [34] The economic burden of hypertension, heart failure, myocardial infarction, and atrial fibrillation in Mexico
    Stevens, Bryce
    Pezzullo, Lynne
    Verdian, Lara
    Tomlinson, Josh
    Estrada-Aguilar, Claudia
    George, Alice
    Verdejo-Paris, Juan
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2018, 88 (03): : 241 - 244
  • [35] CLINICAL AND ECONOMIC BURDEN OF ATRIAL FIBRILLATION IN MEDICARE BENEFICIARIES WITH ACUTE CORONARY SYNDROME
    Chen, S. Y.
    Crivera, C.
    Stokes, M.
    Boulanger, L.
    Schein, J.
    VALUE IN HEALTH, 2013, 16 (03) : A185 - A185
  • [36] Economic burden and resource utilisation in secondary care due to hospitalisation for atrial fibrillation
    Qayyum, S.
    Selvakumar, V.
    Lodwick, R.
    Wilmer, K.
    Petkar, S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1075 - 1075
  • [37] Burden of disease from atrial fibrillation in adults from seven countries in Latin America
    Cubillos, Luz
    Haddad, Alexandra
    Kuznik, Andreas
    Mould-Quevedo, Joaquin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2014, 7 : 441 - 448
  • [38] Prevalence of thromboembolic complications in patients with atrial fibrillation in relation to a selected antithrombotic therapy
    Zavalova, Veronika Muller
    Zizlavsky, Vaclav
    Staffa, Robert
    BIOMEDICAL PAPERS-OLOMOUC, 2013, 157 : S71 - S74
  • [39] Prevalence of cardiovascular risk factors and financial burden in younger adults hospitalized with atrial fibrillation
    Shah, Jay
    Kumar, Ashish
    Majmundar, Monil
    Adalja, Devina
    Doshi, Abhi
    Desai, Rupak
    Patel, Palakkumar
    Doshi, Rajkumar
    HEART & LUNG, 2020, 49 (04): : 393 - 397
  • [40] A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
    Murphy, Niamh F.
    Simpson, Colin R.
    Jhund, Pardeep S.
    Stewart, Simon
    Kirkpatrick, Michelle
    Chalmers, Jim
    MacIntyre, Kate
    McMurray, John J. V.
    HEART, 2007, 93 (05) : 606 - 612